title: Why are so few degradable polymeric biomaterials currently established in clinical applications?
authors.forename: Andreas
authors.initials: A
authors.lastname: Lendlein
authors.forename: Axel T
authors.initials: AT
authors.lastname: Neffe
authors.forename: Benjamin F
authors.initials: BF
authors.lastname: Pierce
authors.forename: Jörg
authors.initials: J
authors.lastname: Vienken
mesh_terms: D020341:Absorbable Implants; D000818:Animals; D001672:Biocompatible Materials; D004337:Drug Carriers; D004867:Equipment Design; D006801:Humans; D008422:Materials Testing; D011108:Polymers / Q000009:adverse effects / Q000737:chemistry* / Q000378:metabolism; D013997:Time Factors; D057170:Translational Research, Biomedical
chemical_list: D001672:Biocompatible Materials; D004337:Drug Carriers; D011108:Polymers